INMB
INmune Bio Inc
NASDAQ: INMB · HEALTHCARE · BIOTECHNOLOGY
$1.33
-5.00% today
Updated 2026-04-29
Market cap
$39.08M
P/E ratio
—
P/S ratio
781.61x
EPS (TTM)
$-1.86
Dividend yield
—
52W range
$1 – $8
Volume
0.4M
INmune Bio Inc (INMB) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-18118.00 | $-317379.00 | $-761834.00 | $-2.06M | $-5.38M | $-8.94M | $-28.50M | $-22.69M | $-11.98M | $-33.36M | $-22.58M |
| Capital expenditures | $0.00 | $0.00 | $100000.00 | $0.00 | $0.00 | $4.00 | $15.00M | $0.00 | $0.00 | $0.00 | $1.04M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $120000.00 | — | $199556.00 | $10.00M | $4.10M | $3.11M | $4.80M | $7.15M | $7.37M | $7.61M | $9.91M |
| Free cash flow | $-18118.00 | $-317379.00 | $-861834.00 | $-2.06M | $-5.38M | $-8.94M | $-43.50M | $-22.69M | $-11.98M | $-33.36M | $-23.62M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $-1.18M | $6.81M | $14.97M | $52.84M | $-21.96M | — | — | — |